Search results for "high-density lipoprotein-cholesterol"

showing 2 items of 2 documents

Uric acid is linked to cardiometabolic risk factors in overweight and obese youths.

2018

OBJECTIVE Observational studies have indicated that high levels of serum uric acid are associated with the risk of cardiovascular disease. The aim of the present study is to investigate the association of uric acid with individual cardiometabolic risk factors, as well as their degree of clustering, in overweight and moderate obese youth. METHODS Three hundred and thirty-three Caucasians of both sexes (149 women), from 5-18 years of age from those who underwent an assessment of overweight/obesity. Anthropometric parameters, office and 24-h blood pressure measurements and metabolic profile, including HDL-cholesterol, triglycerides, insulin, HOMA index and uric acid were assessed. RESULTS Uric…

MalePhysiologymedicine.medical_treatmentoffice blood pressureBlood Pressure030204 cardiovascular system & hematologyOverweightBody Mass Indexchemistry.chemical_compound0302 clinical medicineRisk FactorsInsulinChildyouthAnthropometryCardiovascular DiseasesChild PreschoolFemalemedicine.symptomWaist CircumferenceCardiology and Cardiovascular Medicinemedicine.medical_specialtyWaistAdolescentBirth weight030209 endocrinology & metabolism03 medical and health sciencesInternal medicineInternal MedicinemedicineHumanstriglycerideObesityRisk factorTriglyceridesbusiness.industryInsulinCholesterol HDLbirth weightnutritional and metabolic diseasesBlood Pressure DeterminationOverweightmedicine.diseaseObesityUric AcidEndocrinologyBlood pressurechemistryUric acidhigh-density lipoprotein-cholesterol24-h blood pressureInsulin ResistancebusinessJournal of hypertension
researchProduct

Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?

2012

As the population becomes more obese and the prevalence of diabetes and the metabolic syndrome increases, low-density lipoprotein-cholesterol (LDL-C) may lose its value as a sole predictor for cardiovascular risk among lipids. Combined dyslipidemia is typically characterized by elevations in LDL-C and triglyceride levels, often accompanied by decreased high-density lipoproteincholesterol (HDL-C) concentrations and increased levels of small, dense LDL. This common disorder results from overproduction of hepatically synthesized apolipoprotein B in very low-density lipoproteins. In the last few years most of the international scientific guidelines as well as several expert panels have confirme…

medicine.medical_specialtyApolipoprotein BPopulationCombined dyslipidemia cholesterol low-density lipoprotein-cholesterol small dense low-density lipoprotein high-density lipoprotein- cholesterol non-high-density lipoprotein-cholesterolchemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusDrug DiscoveryAnimalsHumansMedicineeducationTriglyceridesApolipoproteins BDyslipidemiasPharmacologyLdl cholesteroleducation.field_of_studybiologyTriglyceridebusiness.industryCholesterolCholesterol HDLCholesterol LDLAtherosclerosismedicine.diseaseEndocrinologychemistryCardiovascular DiseasesPractice Guidelines as Topicbiology.proteinlipids (amino acids peptides and proteins)Metabolic syndromebusinessDyslipidemiaCurrent Pharmaceutical Design
researchProduct